Chu Maggie 4
4 · LITTELFUSE INC /DE · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Littelfuse (LFUS) SVP Maggie Chu Exercises Options, Sells Shares
What Happened
- Maggie Chu, SVP and Chief Human Resources Officer at Littelfuse (LFUS), exercised 11,397 stock options on 2026-05-20 and sold the same number of shares that day. Exercises: 4,030 shares @ $231.64 ($933,509), 4,283 shares @ $240.76 ($1,031,175), and 3,084 shares @ $230.39 ($710,523) — total exercised cost shown $2,675,207. Sales: 8,926 shares @ $435.22 ($3,884,774), 2,408 shares @ $436.38 ($1,050,803), and 63 shares @ $437.37 ($27,554) — total proceeds ~$4,963,131. Transaction codes: M = option exercise, S = sale.
Key Details
- Transaction date: 2026-05-20 (Form 4 filed 2026-05-21 — timely filing).
- Exercise details (costs): 4,030 @ $231.64; 4,283 @ $240.76; 3,084 @ $230.39.
- Sale details (weighted averages): 8,926 @ $435.22 (range $435.00–$435.94, F1); 2,408 @ $436.38 (range $436.02–$436.93, F2); 63 @ $437.37 (range $437.02–$437.72, F3).
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Notable footnotes: vesting schedules noted for the option grants (vested in one-third increments beginning one year after grants in 2022, 2023, 2024 — F4–F6). Exhibit 24 (Power of Attorney) included.
- No 10b5‑1 plan, gifts, or late-filing flags were indicated in the provided data.
Context
- This is an exercise of options immediately followed by same‑day sales (common "cashless" pattern): the filing shows acquisition by exercise (M) and concurrent disposition (S) of the same number of shares, rather than an open‑market purchase. Such transactions are often routine for covering option exercise costs, tax withholding, or taking gains; they are not, by themselves, a clear buy/sell sentiment signal.
Insider Transaction Report
Form 4
Chu Maggie
SVP, CHRO
Transactions
- Exercise/Conversion
Common Stock
2026-05-20$231.64/sh+4,030$933,509→ 10,031 total - Exercise/Conversion
Common Stock
2026-05-20$240.76/sh+4,283$1,031,175→ 14,314 total - Exercise/Conversion
Common Stock
2026-05-20$230.39/sh+3,084$710,523→ 17,398 total - Sale
Common Stock
[F1]2026-05-20$435.22/sh−8,926$3,884,774→ 8,472 total - Sale
Common Stock
[F2]2026-05-20$436.38/sh−2,408$1,050,803→ 6,064 total - Sale
Common Stock
[F3]2026-05-20$437.37/sh−63$27,554→ 6,001 total - Exercise/Conversion
Stock Option (right to buy)
[F4]2022-04-28−4,030→ 0 totalExercise: $231.64Exp: 2029-04-28→ Common Stock (4,030 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F5]2023-04-27−4,283→ 0 totalExercise: $240.76Exp: 2030-04-27→ Common Stock (4,283 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F6]2024-04-25−3,084→ 1,542 totalExercise: $230.39Exp: 2031-04-25→ Common Stock (3,084 underlying)
Footnotes (6)
- [F1]The shares were sold in multiple transactions at prices ranging from $435.00 to $435.94, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F2]The shares were sold in multiple transactions at prices ranging from $436.02 to $436.93, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]The shares were sold in multiple transactions at prices ranging from $437.02 to $437.72, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F4]The option for 4,030 shares vested in increments of one third annually beginning on the first anniversary of the April 28, 2022 date of grant.
- [F5]The option for 4,283 shares vested in increments of one third annually beginning on the first anniversary of the April 27, 2023 date of grant.
- [F6]The option for 4,626 shares vested in increments of one third annually beginning on the first anniversary of the April 25, 2024 date of grant.
Signature
/s/Anne-Marie D'Angelo, Power of Attorney|2026-05-21